Rush offering new motion sensor technology found in smart phones for chronic pain relief

March 13, 2012 in Other

Experts from the Rush Pain Center at Rush University Medical Center are the first in Chicago to offer patients a neurostimulation system that uses new, motion sensor technology found in smart phones and Wii video gaming systems to help patients manage chronic leg and back pain.

The AdaptiveStim with RestoreSensor is an similar to a pacemaker that interrupts from reaching the brain. It is the only chronic pain treatment system that can automatically recognize and remember the correlation between the change in body position and the level of stimulation needed. The system can also record and store the frequency of posture changes and automatically adjust stimulation in order to provide effective pain relief.

"This device is unique because its motion-detecting technology enables it to automatically adjust the intensity of stimulation based on the patient’s body position," said Dr. Sandeep Amin, pain specialist and assistant professor of anesthesiology at Rush. "The device memorizes and records the level of stimulation a patient uses while in a particular position; the next time the patient is in that position, the device adjusts the stimulation to the appropriate level."

Neurostimulators are a mainstay of chronic pain management, but the drawback of these neurostimulators is that they require patients to manually adjust the level of stimulation, using a handheld programmer, every time they change . Without adjusting for these changes, patients may continue to experience pain.

"It’s like flipping a switch," said Amin. "Patients appreciate the convenience of not having to make frequent adjustments in order to remain pain-free."

The tiny, pacemaker-like device is implanted in a patient’s back though a small incision. During the procedure, thin, thread wires containing electrodes that emit charges to change a painful stimulus to a tingling sensation are secured along the outside of the spine.

Patients can typically be back on their feet in about two days and back to normal activities in six to eight weeks. The implanted battery has to be changed – a 45-minute procedure – once every four to seven years.

"This new device also has the ability to provide feedback to help us understand how a patient’s individual stimulation requirements change over time," said Amin.

An estimated 116 million American adults are affected by chronic pain, a debilitating and often disabling condition that can have significant impact on day-to-day functioning.

The AdaptiveStim with RestoreSensor device is made by Medtronic.

Provided by Rush University Medical Center search and more info website

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts

More news stories

Future doctors unaware of their obesity bias

Two out of five medical students have an unconscious bias against obese people, according to a new study by researchers at Wake Forest Baptist Medical Center. The study is published online ahead of print in the Journal of ...

Other created 1 hour ago | popularity not rated yet | comments 0

Plastic realistic: Medical students to use plastinated human bodies for anatomy learning

Nanyang Technological University's (NTU) new medical school will be pioneering the use of plastinated bodies for medical education in Singapore.

Other created 10 hours ago | popularity not rated yet | comments 0

Survey points out deficiencies in addictions training for medical residents

A 2012 survey of internal medicine residents at Massachusetts General Hospital (MGH) – one of the nation's leading teaching hospitals – found that more than half rated the training they had received in addiction and other ...

Other created May 22, 2013 | popularity 5 / 5 (1) | comments 0

Early use of tracheostomy for mechanically ventilated patients not associated with improved survival

For critically ill patients receiving mechanical ventilation, early tracheostomy (within the first 4 days after admission) was not associated with an improvement in the risk of death within 30 days compared to patients who ...

Other created May 21, 2013 | popularity not rated yet | comments 0

Decisions to forgo life support may depend heavily on the ICU where patients are treated

The decision to limit life support in patients in the intensive care unit (ICU) appears to be significantly influenced by physician practices and/or the culture of the hospital, suggests new findings from researchers at the ...

Other created May 21, 2013 | popularity not rated yet | comments 0


Glucosamine supplements tied to risk of eye condition

(HealthDay)—Glucosamine supplements that millions of Americans take to help treat hip and knee osteoarthritis may have an unexpected side effect: They may increase risk for developing glaucoma, a small ...

Controlling mood through the motions of mitochondria

(Medical Xpress)—Regulating the distribution of power in neurons is done by a system that makes the national electric grid look simple by comparison. Each neuron has several thousand mitochondria confined ...

WHO: Scientific red tape mars efforts vs. virus

International efforts to combat a new pneumonia-like virus that has now killed 22 people are being slowed by unclear rules and competition for the potentially profitable rights to disease samples, the head ...

Scientists discover molecule triggers sensation of itch

Scientists at the National Institutes of Health report they have discovered in mouse studies that a small molecule released in the spinal cord triggers a process that is later experienced in the brain as ...

Multiple research teams unable to confirm high-profile Alzheimer's study

Teams of highly respected Alzheimer's researchers failed to replicate what appeared to be breakthrough results for the treatment of this brain disease when they were published last year in the journal Science.

When oxygen is short, EGFR prevents maturation of cancer-fighting miRNAs

Even while being dragged to its destruction inside a cell, a cancer-promoting growth factor receptor fires away, sending signals that thwart the development of tumor-suppressing microRNAs (miRNAs) before it's dissolved, researchers ...